Parathyroid Hormone: Structure, Function and Dynamic Actions

Dynamics of Bone and Cartilage Metabolism

Volumn , Issue , 2006, Pages 273-291

  Fitzpatrick, Lorraine A ^a   Bilezikian, John P ^b  

^a AMGEN INC   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882528579     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088562-6/50017-0     Document Type: Chapter

References (147)

1. Miric A., Levine M.A. Analysis of the preproPTH gene by denaturing gradient gel electrophoresis in familial isolated hypoparathyroidism. J. Clin. Endocrinol. Metab. 1992, 74:509-516.
2. Kronenberg H.M., Igarashi T., Freeman M.W., Okazaki T., Brand S.J., Wiren K.M., Potts J.T. Structure and expression of the human parathyroid hormone gene. Recent. Prog. Horm. Res. 1986, 42:641-663.
3. Demay M.B., Kiernan M.S., DeLuca H.F., Kronenberg H.M. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc. Natl Acad. Sci. USA 1992, 89:8097-8101.
4. Kilav R., Silver J., Naveh-Many T. Parathyroid hormone gene expression in hypophosphatemic rats. J. Clin. Invest. 1995, 96:327-333.
5. Moallem E., Silver J., Kilav R., Naveh-Many T. RNA protein binding and post-transcriptional regulation of PTH gene expression by calcium and phosphate. J. Biol. Chem. 1998, 273:5253-5259.
6. Antonarakis S.E., Phillips J.A., Mallonee R.L., Kazazian H.H.J., Fearon E.R., Waber P.G., Kronenberg H.M., Ullrich A., Meyers D.A. Beta-globin locus is linked to the parathyroid hormone (PTH) locus and lies between the insulin and PTH loci in man. Proc. Natl Acad. Sci. USA 1983, 80:6615-6619.
7. Mayer H., Breyel E., Bostock C., Schmidtke J. Assignment of the human parathyroid hormone gene to chromosome 11. Hum. Genet. 1983, 64:283-285.
8. Zabel B.U., Kronenberg H.M., Bell G.I., Shows T.B. Chromosome mapping of genes on the short arm of human chromosome 11: parathyroid hormone gene is at 11p15 together with the genes for insulin, c-Harvey-ras 1, and b-hemoglobin. Cytogenet. Cell Genet. 1985, 39:200-205.
9. Miao D., He B., Karaplis A.C., Goltzman D. Parathyroid hormone is essential for normal fetal bone formation. J. Clinical Invest. 2002, 109:1173-1182.
10. Miao D., He B., Lanske B., et al. Skeletal abnormalities in PTH-null mice are influenced by dietary calcium. Endocrinology 2004, 145:2046-2053.
11. Zhou X-G., Liu Y-Z., Li, et al. Parathyroid hormone gene with bone phenotypes in Chinese. Biochem. Biophys. Res. Comm. 2003, 307:666-671.
12. Goswami R., Mohappatra T., Gupta N., et al. Parathyroid hormone gene polymorphism and sporadic idiopathic hypoparathyroidism. J. Clin. Endocrinol. Metab. 2004, 89:4840-4845.
13. Gong G., Johnson M.L., Barger-Lux M.J., Heaney R.P. Association of bone dimensions with a parathyroid hormone gene polymorphism in women. Osteoporosis Int. 1999, 9:307-311.
14. Gohda T., Shou I., Fukui M., et al. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients. J. Kidney Dis. 2002, 39:1255-12560.
15. Kanzawa M., Sugimoto T., Kobayashi T., Kobayashi A., Chihara K. Parathyroid hormone gene polymorphisms in primary hyperparathyroidism. Clin. Endocrinol. 1999, 50:583-588.
16. Sunthornthepvarakul T., Churesigaew S., Ngowngarmratana S. A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism. J. Clin. Endocrinol. Metab. 1999, 84:3792-3796.
17. Russell J., Lettieri D., Sherwood L.M. Direct regulation of calcium of cytoplasmic messenger ribonucleic acid coding for preproparathyroid hormone in isolated bovine parathyroid cells. J. Clin. Invest. 1983, 72:1851-1855.
18. Naveh-Many T., Friedlander M.M., Mayer H., Silver J. Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D. Endocrinology 1989, 125:275-280.
19. Brown E.M. Editorial: mutant extracellular calcium-sensing receptors and severity of disease. J. Clin. Endocrinol. Metab. 2005, 90:1246-1248.
20. 2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J. Bone Miner. Res. 1997, 12:715-725.
21. Kifor O., MacLeod R.J., Diaz R., Bai M., Yamaguchi T., Yao T., Kifor I., Brown E.M. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am. J. Physiol. Renal. Physiol. 2001, 280:F291-F302.
22. Parfitt A.M. Parathyroid growth. The Parathyroids Basic and Clinical Concepts 2001, 293-329. Academic Press, San Diego, CA. 2nd ed. J.P. Bilezikian, R. Marcus, M.A. Levine (Eds.).
23. Okazaki T., Zajac J.D., Igarashi T., Ogata E., Kronenberg H.M. Negative regulatory elements in the human parathyroid hormone gene. J. Biol. Chem. 1991, 266:21903-21910.
24. Moallem E., Kilav R., Silver J., Naveh-Many T. RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphatase. J. Biol. Chem. 1998, 273:5253-5259.
25. Hawa N.S., O'Riordan J.L., Farrow S.M. Posttranscriptional regulation of bovine parathyroid hormone synthesis. J. Mol. Endocrinol. 1993, 10:43-49.
26. Vadher S., Hawa N.S., O'Riordan J.L., Farrow S.M. Translational regulation of parathyroid hormone gene expression and RNA: protein interactions. J. Bone Miner. Res. 1996, 11:746-753.
27. Kilav R., Bell O., Le S-Y., Silver J., Naveh-Many T. The parathyroid hormone mRNA3?-untranslated region AU-rich element is an unstructured functional element. J. Biol. Chem. 2004, 279:2109-2116.
28. Silver J., Russell J., Sherwood L.M. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc. Natl Acad. Sci. USA 1985, 82:4270-4273.
29. 3 of transcription of the pre-proparathyroid hormone gene. Endocrinology 1986, 119:2864-2866.
30. Silver J., Naveh-Many T., Mayer H., Schmelzer H.J., Popovtzer M.M. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J. Clin. Invest. 1986, 78:1296-1301.
31. 3. J. Biol. Chem. 1988, 263:2203-2208.
32. Mackey S.L., Heymont J.L., Kronenberg H.M., Demay M.B. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol. Endocrinol. 1996, 10:298-305.
33. Sela-Brown A., Russell J., Koszewski N.J., et al. Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats. Mol. Endocrinol. 1998, 12:1193-1200.
34. Slatopolsky E., Bricker N.S. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int. 1973, 4:141-145.
35. Lopez-Hilker S., Dusso A.S., Rapp N.S., Martin K.J., Slatopolsky E. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am. J. Physiol. 1990, 259:F432-F437.
36. Kilav R., Silver J., Biber J., Murer H., Naveh-Many T. Coordinate regulation of the rat renal parathyroid hormone receptor mRNA and the Na-Pi cotransporter mRNA and protein. Am. J. Physiol. 1995, 268:F1017-F1022.
37. Moallem E., Kilav R., Silver J., Naveh-Many T. RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J. Biol. Chem. 1998, 273:5253-5259.
38. Almaden Y., Hemandez A., Torregrosa V., Campistol J., Torres A., Rodriguez M.S. High phosphorous directly stimulates PTH secretion by human parathyroid tissue. J. Am. Soc. Nephrol. 1995, 6:957.
39. 3 in the parathyroid in vivo. J. Clin. Invest. 1990, 86:1968-1975.
40. Russell J., Bar A., Sherwood L.M., Hurwitz S. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Endocrinology 1993, 132:2639-2644.
41. Brown A.J., Zhong M., Finch J., Ritter C., Slatopolsky E. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 1995, 136:1419-1425.
42. 3. J. Biol. Chem. 1988, 263:2203-2208.
43. 3 through nuclear factor Y. Biochem. Biophys. Res. Commun. 2005, 328:831-837.
44. Peraldi M.N., Rondeau E., Jousset V., et al. Dexamethasone increases preproparathyroid hormone messenger RNA in human hyperplastic parathyroid cell in vitro. Eur. J. Clin. Invest. 1990, 20:392-397.
45. 3 and cortisol on bovine and human parathyroid cells. J. Endocrinol. 1989, 123:137-142.
46. Moallem E., Silver J., Naveh-Many T. Regulation of parathyroid hormone messenger RNA levels by protein kinase A and C in bovine parathyroid cells. J. Bone Miner. Res. 1995, 10:447-452.
47. Clarke B.L., Hassager C., Fitzpatrick L.A. Regulation of parathyroid hormone release by protein kinase-C is dependent on extracellular calcium in bovine parathyroid cells. Endocrinology 1993, 132:1168-1175.
48. Naveh-Many T., Almogi G., Livni N., Silver J. Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J. Clin. Invest. 1992, 90:2434-2438.
49. Epstein E., Silver J., Almogi G., Livni N., Naveh-Many T. Parathyroid hormone mRNA levels are increased by progestins and vary during the rat estrous cycle. Am. J. Physiol. 1996, 33:E158-E163.
50. Murray T.M., Rao L.G., Divieti P., Bringhurst F.R. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocrine Rev. 2005, 26:78-113.
51. Kronenberg H.M., Bringhurst F.R., Segre G.V., Potts J.T. Parathyroid hormone biosynthesis and metabolism. The Parathyroids Basic and Clinical Concepts 1994, 125-137. Raven Press, Ltd., New York. J.P. Bilezikian, R. Marcus, M.A. Levine (Eds.).
52. Lazure C., Gauthier D., Jean F., Boudreault A., Seidah N.G., Bennett H.P., Hendy G.N. In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor. J. Biol. Chem. 1998, 273:8572-8580.
53. Habener J.F., Kemper B., Potts J.T. Calcium-dependent intracellular degradation of parathyroid hormone: a possible mechanism for the regulation of hormone stores. Endocrinology 1975, 97:431-441.
54. Chu L.L.H., MacGregor R.R., Anast C.S., et al. Studies on the biosynthesis of rat parathyroid hormone and proparathyroid horn one: adaptation of the parathyroid gland to dietary restriction of calcium. Endocrinology 1973, 93:915-924.
55. Bringhurst F.R., Stern A.M., Yotts M., Mizrahi N., Segre G.V., Potts J.T. Peripheral metabolism of PTH: fate of biologically active amino terminus in vivo. Am. J. Physiol. 1988, 255:E886-E893.
56. Bringhurst F.R., Segre G.V., Lampman G.W., Potts J.T. Metabolism of parathyroid hormone by Kupffer cells: analysis by reverse-phase high-performance liquid chromatography. Biochemistry 1982, 21:4252-4258.
57. Yasuda T., Banville D., Hendy G.N., Goltzman D. Characterization of the human parathyroid hormone-like peptide gene: functional and evolutionary aspects. J. Biol. Chem. 1989, 264:7720-7725.
58. Caulfield M.P., McKee R.L., Goldman M.E., et al. The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region. Endocrinology 1990, 127:83-87.
59. Strewler G.J., Stern P.H., Jacobs J.W., et al. Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J. Clin. Invest. 1987, 80:1803-1807.
60. Suva L.J., Winslow G.A., Wettenhall R.E., et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia, cloning and expression. Science 1987, 237:893-896.
61. Kapf D.B., Arnaud C.D., Bambino T., et al. Structure properties of the renal parathyroid hormone receptor: hydrodynamic analysis and protease sensitivity. Endocrinology 1988, 123:2611-2619.
62. Jüppner H., Abou-Samra A.B., Freeman M., et al. AG Protein-linked receptor for parathyroid hormone and parathyroid hormonerelated peptide. Science 1991, 254:1024-1026.
63. Schipani E., Karga H., Karaplis A.C., et al. Identical cDNAs encode a human renal and bone parathyroid hormone/parathyroid hormone-related peptide receptor. Endocrinology 1993, 132:2157-2165.
64. Iida-Klein A., Guo J., Xie L.Y., et al. Trunication of the carboxyl-terminal region of the rat parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of the adenylyl cyclase but not phospholipase C. J. Biol. Chem. 1995, 270:8458-8465.
65. Bringhurst F.R., Juppner H., Guo J., P.Urena, Potts J.T., Kronenberg H.M., Abou-Samra A.B., Segre G.V. Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells. Endocrinology 1993, 132:2090-2098.
66. Huang Z., Chen Y., Pratt S., Chen T.H., Bambino T., Nissenson R.A., Shoback D.M. The N-terminal region of the third intracellular loop of the parathyroid hormone (PTH)/PTH-related peptide receptor is critical for coupling to cAMP and inositol phosphate/Ca2+ signal transduction pathways. J. Biol. Chem. 1996, 271:33382-33389.
67. Schipani E., Langman C.B., Parfitt A.M., et al. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphy seal chondrodysplasia. New Engl. J. Med. 1996, 335:708-714.
68. Turner P.R., Bambino T., Nissenson R.A. A putative selectivity filter in the G-protein-coupled receptors for parathyroid hormone and secretion. J. Biol. Chem. 1996, 271:9205-9208.
69. Sneddon W.B., Syme C.A., Bisello, et al. Activation-independent parathyroid hormone receptor internalization is regulated by NHERFl (EBP50). J. Biol. Chem. 2003, 278:43787-43796.
70. Majesca R.J., Rodan S.B., Rodan G.A. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 1980, 107:1494-1503.
71. Chase L.R., Fedak S.A., Aurbach G.D. Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. Endocrinology 1969, 84:761-768.
72. Chase L.R., Melson G.L., Aurbach G.D. Pseudohypoparathyroidism: defective excretion of 3?, 5?-AMP in response to parathyroid hormone. J. Clin. Invest. 1969, 48:1832-1844.
73. Tregear G.W., Van Rietschoten J., Greene E., et al. Bovine parathyroid hormone: Minimum chain length of synthetic peptide required for biological activity. Endocrinology 1973, 93:1349-1353.
74. Partridge N.C., Alcom D., Michelangeli V.P., Kemp B.E., Ryan G.B., Martin T.J. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 1981, 108:213-219.
75. Rasmussen H. The calcium messenger system (first of two parts). N. Engl. J. Med. 1986, 314:1094-1101.
76. Rasmussen H. The calcium messenger system (second of two parts). N. Engl. J. Med. 1986, 314:1164-1170.
77. Ohno S., Akita Y., Hata O., Osada S., Kubo K., Konno Y., et al. Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family, two distinct classes of PKC, conventional cPKC and novel nPKC. Advan. Enzyme Reg. 1991, 31:287-303.
78. Singh A.T.K., Bhattacharyya R.S., Radeff J.M., Stern P.H. Regulation of parathyroid hormone-stimulated phospholipase D in UMR-106 cells by calcium, MAP kinase, and small G Proteins. J. Bone Miner: Res. 2003, 18:1453-1460.
79. Radeff J.M., Singh A.T.K., Stern P.H. Role of protein kinase A, phospholipase C and phospholipase D in parathyroid hormone receptor regulation of protein kinase C? and interleukin-6 in UMR-106 osteoblastic cells. Cell Signalling 2004, 16:105-114.
80. Turner P.R., Mefford S., Bambino T., Nissenson R.A. Transmembrane residues to gether with the amino terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide. J. Biol. chem. 1998, 273:3830-3837.
81. Bergwitz C., Jusseaume S.A., Luck M.D., Juppner H., Gardella T.J. Residues in the membrane-spanning and extracellular loop regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide. J. Biol. Chem. 1997, 272:28861-28868.
82. Gensure R.C., Ponugoti B., Gunes Y., et al. Identification and characterization of two parathyroid hormone-like molecules in zebrafish. Endocrinology 2004, 145:1634-1639.
83. Takasu H., Baba H., Inomata N., et al. The 69-84 amino acid region of the parathyroid hormone molecule is essential for the interaction of the hormone with the binding sites with carboxyl-terminal specificity. Endocrinology 1996, 137:5537-5543.
84. Murray T.M., Rao L.G., Muzaffar S.A. Dexamethasonetreated ROS17/2.8 rat osteosarcoma cells are responsive to human carboxylterminal parathyroid hormone peptide hPTH (53-84): stimulation of alkaline phosphatase. Calcif. Tiss. Int. 1991, 49:120-123.
85. Inomata N., Akiyama M., Kubota N., Jüppner H. Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH-(1-84). Endocrinology 1995, 136:4732-4740.
86. Divieti P., Inomata N., Chapin K., Singh R., Jüppner H., Bringhurst F.R. Receptors for the carboxyl-terminal region of PTH (1-84) are highly expressed in osteocytic cells. Endocrinology 2001, 142:916-925.
87. Divieti P., Geller A.I., Sulima G., Jüppner H., Bringhurst F.R. Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrinology 2005, 146:1863-1870.
88. Eichinger A., Fiaschi-Taesch N., Massfelder T., Fritsch S., Barthelmebs M., Helwig J.J. Transcript expression of the turberoinfundibular peptide (TIP)39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels. Endocrinology 2002, 143:30336-30343.
89. John M.R., Arai M., Rubin D.A., Jonsson K.B., Jüppner H. Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues. Endocrinology 2002, 143:1047-1057.
90. McSheehy P.M.J., Chambers T.J. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 1986, 118:824-828.
91. Martin T.J., Udagawa N. Hormonal regulation of osteoclast function. Trends Endocrinol. Metab. 1998, 9:6-12.
92. Roodman G.D. Osteoclast differentiation and activity. Biochem. Soc. Trans. 1998, 26:7-13.
93. Talmage R.V., et al. The demand for bone calcium in maintenance of plasma calcium concentration. Mechanisms of Localized Bone Loss 1978, 73-91. Information Retrieval, Washington, DC. J.E. Horton, T.M. Tarplay, W.F. Davis (Eds.).
94. Rodan G.A., Martin T.J. Role of osteoblasts in hormonal control of bone resorption-a hypothesis. Calcif. Tiss. Int. 1981, 33:349.
95. Liu B.Y., Guo J., Lanske B., Divieti P., Kronenberg H.M., Bringhurst F.R. Conditionally immortalized murine bone marrow strornal cells mediate parathyroid hormone-dependent osteoclastogenesis in vitro. Endocrinology 1998, 139:1952-1964.
96. +-ATPase, inhibits bone resorption in vitro. Calcif. Tiss. Int. 1986, 38:123-125.
97. Hall G.E., Kenny A.D. Bone resorption induced by parathyroid hormone and dibutyryl cyclic AMP: role of carbonic anhydrase. J. Pharmacol. Exp. Ther. 1986, 223:778-782.
98. Krieger N.S., Kim S.G. Dichlorobenzamil inhibits stimulated bone resorption in vitro. Endocrinology 1988, 122:415-420.
99. Bushinsky D.A. Effects of parathyroid hormone on net proton flux from neonatal mouse calvariae. Am. J. Physiol. 1987, 252(4, part 2):F585-F589.
100. Catherwood B.D., Titus L., Evans C.O., Rubin J., Boden S.D., Nanes M.S. Increased expression of tissue plasminogen activator messenger ribonucleic acid is an immediate response to parathyroid hormone in neonatal rat osteoblasts. Endocrinology 1994, 134:1429-1436.
101. Midura R.J., Evanko S.P., Hascall V.C. Parathyroid hormone stimulates hyaluronan synthesis in an osteoblast-like cell line. J. Biol. Chem. 1994, 269:13200-13206.
102. Selvamurugan N., Chou W.Y., Pearman A.T., Pulumati M.R., Partridge N.C. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J. Biol. Chem. 1998, 273:10647-10657.
103. Babich M., Foti L.R. E-cadherins identified in osteoblastic cells: effects of parathyroid hormone and extracellular calcium on localization. Life Sci. 1994, 54:201-208.
104. Schlüter K.D., Hellstern H., Wingender E., Mayer H. The central part of parathyroid hormone stimulates thymidine incorporation of chondrocytes. J. Biol. Chem. 1989, 264:11087-11092.
105. Hall A.K., Dickson I.R. The effects of parathyroid hormone on osteoblast-like cells from embryonic chick calcaria. Acta Endocrinol. 1985, 108:217-233.
106. Heath J.K., Atkinson S.J., Meikle M.C., Reynolds J.J. Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochim. Biophys. Acta 1984, 802:151-154.
107. Simon L.S., Slovik S.M., Neer R.M., Krane S.M. Changes in serum levels of type I and III procollagen extension peptides during infusion of human parathyroid hormone fragment (1-34). J. Bone Miner. Res. 1988, 3:241-246.
108. Nasu M., Sugimoto T., Kaji H., et al. Carboxyl-terminal parathyroid hormone fragments stimulate type-1 procollagen and insulin-like growth factor-binding protein-5 mRNA expression in osteoblastic UMR-106 cells. Endocr. J. 1998, 45:229-234.
109. Armbrecht J.H., Hodam T.L. Parathyroid hormone and 1,25-dihydroxyvitamin D synergistically induce the 1,25-dihydroxy-vitamin D-24-hydroxylase in rat UMR-106 osteoblast-like cells. Biochem. Biophys. Res. Commun. 1994, 205:674-679.
110. Alvarez M., Thunyakitpisal P., Morrison P., Onyia J., Hock J., Bidwell J.P. PTH-responsive osteoblast nuclear matrix architectural transcription factor binds to the rat type I collagen promoter. J. Cell Biochem. 1998, 69:336-352.
111. Torrungruang K., Feister H., Swartz D., et al. Parathyroid hormone regulates the expression of the nuclear mitotic apparatus protein in the osteoblast-like cells. Bone 1998, 22:317-324.
112. Feister H.A., Onyia J.E., Miles R.R., et al. The expression of the nuclear matrix proteins NuMA, topoisomerase II-? and -? in bone and osseous cell culture: regulation by parathyroid hormone. Bone 2000, 26:227-234.
113. Qin L., Tarnasis J., Raggatt L., et al. Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J. Biol. Chem. 2005, 280:3974-3981.
114. Massas R., Benayahu D. Parathyroid hormone effect on cell-to-cell communication in stromal and osteoblastic cells. J. Cell. Biochem. 1998, 69:81-86.
115. Schiller P.C., Roos B.A., Howard G.A. Parathyroid hormone up-regulation of connexin 43 gene expression in osteoblasts depends on cell phenotype. J. Bone Miner. Res. 1997, 12:2005-2013.
116. Civitelli R., Ziambaras K., Warlow P.M., Lecanda R., Nelson T., Harley J., Atal N., Beyer E.C., Steinberg T.H. Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells. J. Cell Biochem. 1998, 68:8-21.
117. Elias J.A., Tang W., Horowitz M.C. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 1995, 136:489-498.
118. Schmid C., Schlapfer I., Peter M., Boni-Schnetzler M., Schwander J. Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. Am. J. Physiol. 1994, 267:E226-E233.
119. Conover C.A. Insulin-like growth factor binding protein proteolysis in bone cell models. Prog. Growth Factor Res. 1995, 6:301-309.
120. Kano J., Sugimoto T., Kanatani M., Kuroki Y., Tsukamoto T., Fukase M., Chinara K. Second messenger signaling of c-fos gene induction by parathyroid hormeon (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: its role in osteoblast proliferation and osteoclast-like cell formation. J. Cell. Physiol. 1994, 161:358-366.
121. Nemere I., Larsson D. Does PTH have a direct effect on intestine?. J. Cell. Biochem. 2002, 86:29-34.
122. Hruska K.A., Blondin J., Bass R., et al. Effect of intact parathyroid hormone on hepatic glucose release in the dog. J. Clin. Invest. 1979, 64:1016-1023.
123. Puschett J.B., McGowan J., Fragola J., Chen T.C., et al. Difference between 1-84 parathyroid hormone and the 1-34 fragment on renal tubular calcium transport in the dog. Miner. Electrolyte Metab. 1984, 10:271-274.
124. Toromanoff A., Ammann P., Riond J.L. Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats. Bone 1998, 22:217-223.
125. Kishi T., Hagino H., Kishimoto H., et al. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration. Bone 1998, 22:515-522.
126. Okimoto N., Tsurukami H., Okazaki Y., et al. Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats. Bone 1998, 22:523-531.
127. Lane N.E., Kimmel D.B., Nilsson M.H., Cohen F.E., Newton S., Nissenson R.A., Strewler G.J. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model. J. Bone Miner. Res. 1996, 11:614-625.
128. Ejersted C., Oxlund H., Eriksen E.F., et al. Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and end ocortical bone in old rats. Bone 1998, 23:43-52.
129. Chow J.W.M., Fox S., Jagger C.J., et al. Role for parathyroid hormone in mechanical responsiveness of rat bone. Am. J. Physiol. Endocrin. Metab. 1998, 37:E146-E154.
130. Schipani E., Lanske B., Hunzelman J., et al. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc. Natl. Acad. Sci. USA 1997, 94:13689-13694.
131. Karaplis A.C., Luz A., Glowacki J., et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Development 1994, 8:277-289.
132. Lanske B., Karaplis A.C., Lee K., et al. PTH/PTHrP receptor in early development and indian hedgehog-regulated bone growth. Science 1996, 273:663-666.
133. Jobert A-S., Zhang P., Couvineau A., et al. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in blomstrand chondrodysplasia. J. Clin. Invest. 1998, 102:34-40.
134. Karaplis A.C., He B., Nguyen M.T.A., et al. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in blomstrand chondrodysplasia. Endocrinology 1998, 139:5255-5258.
135. Zhou H., Iida-Klein A., Lu S.S., et al. Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice. Bone 2003, 32:513-520.
136. Theiler R., Bischoff H., Tyndall A., Stahelin H.B. Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25dihydroxy-vitamin D3 than by vitamin D3. Int. J. Vitam. Nutr. Res. 1998, 68:36-41.
137. Berruti a., Sperone P., Fasolis G., Torta M., Fontana D., Dogliotti L., Angeli A. Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer. Prostate 1997, 33:252-255.
138. Brahm H., Ljunggren O., Larsson K., Lindh E., Ljunghall S. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type 1 collagen. Calcif. Tissue Int. 1994, 55:412-416.
139. Ebeling P.R., Jones J.D., Burritt M.F., Duerson C.R., Lane A.W., Hassager C., Kumar R., Riggs B.L. Skeletal responsiveness to endogenous parathyroid hormone in postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 1992, 75:1033-1038.
140. Ledger G.A., Burritt M.F., Kao P.C., O'Fallon W.M., Riggs B.L., Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J. Clin. Endocrinol. Metab. 1995, 80:3304-3310.
141. Schwietert H.R., Groen E.W., Sollie F.A., Jonkman J.H. Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1-84)] in healthy postmenopausal volunteers. Clin. Pharmacol. Ther. 1997, 61:360-376.
142. Cosman F., Morgan D.C., Nieves J.W., Shen V., Luckey M.M., Dempster D.W., Lindsay R., Parisien M. Resistance to bone resorbing effects of PTH in black women. J. Bone Miner. Res. 1997, 12:958-966.
143. Lindsay R., Nieves J., Formica C., et al. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 1997, 350:550-555.
144. Kurland E.S., Cosman F., McMahon D.J., Shen V., Lindsay R., Rosen C.J., Bilezikian J.P. Changes in bone markers predict bone accural in osteoporotic men treated with parathyroid hormone. J. Bone Miner. Res. 2000, 85:3069-3076.
145. Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New Engl. J. Med. 2001, 344:1434-1441.
146. Gallagher J.C., Genant H.K., Crans G.G., Vargas S.J., Krege J.H. Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. J. Clin. Endocrinol. Metab. 2005, 90:1583-1587.
147. Black D.M., Greenspan S.L., Ensrud K.E., Palmero L., et al. The effects of parathyroid hormone and adendronate alone or in combination in postmenopausal osteoporosis. New Engl. J. Med. 2003, 349:1207-1215.